J. Early-onset gastric cancers possess a distinct molecular expression profile than traditional gastric cancers. Mod. Pathol. 2006, 19, 56472. 120. Young, L.E.; Sanduja, S.; Bemis-Standoli, K.; Pena, E.A.; Price, R.L.; Dixon, D.A. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase two expression in the course of colon carcinogenesis. Gastroenterology 2009, 136, 1669679. 121. Cho, N.P.; Han, H.S.; Soh, Y.; Son, H.J. Overexpression of cyclooxygenase-2 correlates with cytoplasmic HuR expression in salivary mucoepidermoid carcinoma but not in pleomorphic adenoma. J. Oral. Pathol. Med. 2007, 36, 29703. 122. Saunus, J.M.; French, J.D.; Edwards, S.L.; Beveridge, D.J.; Hatchell, E.C.; Wagner, S.A.; Stein, S.R.; Davidson, A.; Simpson, K.J.; Francis, G.D.; et al. Posttranscriptional regulation in the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR. Cancer Res. 2008, 68, 9469478. 123. Woo, H.H.; Yi, X.; Lamb, T.; Menzl, I.; Baker, T.; Shapiro, D.J.; Chambers, S.K. Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer. Mol. Cell Biol. 2011, 31, 21525. 124. Guo, X.; Hartley, R.S. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells. Cancer Res. 2006, 66, 7948956. 125. Yuan, Z.; Sanders, A.J.; Ye, L.; Wang, Y.; Jiang, W.G. Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and impacts expression of cyclin D1 and MMP-9.Mucicarmine Oncol.tBID Rep. 2011, 26, 23745.Int. J. Mol. Sci. 2013,126. L ez de Silanes, I.; Gorospe, M.; Taniguchi, H.; Abdelmohsen, K.; Srikantan, S.; Alaminos, M.; Berdasco, M.; Urdinguio, R.G.; Fraga, M.F.; Jacinto, F.V.; et al. The RNA-binding protein HuR regulates DNA methylation by means of stabilization of DNMT3b mRNA. Nucleic Acids Res. 2009, 37, 2658671. 127. Kakuguchi, W.; Kitamura, T.; Kuroshima, T.; Ishikawa, M.; Kitagawa, Y.; Totsuka, Y.; Shindoh, M.; Higashino, F. HuR knockdown changes the oncogenic potential of oral cancer cells. Mol. Cancer Res. 2010, eight, 52028. 128. Linker, K.; Pautz A.; Fechir M.; Hubrich T.; Greeve J.; Kleinert H. Involvement of KSRP inside the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res. 2005, 33, 4813827. 129. Suzuki, E.; Tsutsumi, A.; Sugihara, M.; Mamura, M.; Goto, D.; Matsumoto, I.; Ito, S.; Ikeda, K.; Ochiai, N.; Sato Y.; et al. Expression of TNF-alpha.; tristetraprolin.; T-cell intracellular antigen-1 and Hu antigen R genes in synovium of individuals with rheumatoid arthritis.PMID:34235739 Int. J. Mol. Med. 2006, 18, 27378. 130. Nabors, L.B.; Gillespie, G.Y.; Harkins, L.; King, P.H. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements inside the 3′ untranslated regions of cytokine and angiogenic issue mRNAs. Cancer Res. 2001, 61, 2154161. 131. Ishimaru, D.; Ramalingam, S.; Sengupta, T.K.; Bandyopadhyay, S.; Dellis, S.; Tholanikunnel, B.G.; Fernandes, D.J.; Spicer, E.K. Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells. Mol. Cancer Res. 2009, 7, 1354366. 132. Pineda, D.M.; Rittenhouse, D.W.; Valley, C.C.; Cozzitorto, J.A.; Burkhart, R.A.; Leiby, B.; Winter, J.M.; Weber, M.C.; Londin, E.R.; Rigoutsos, I.; et al. HuR’s post-transcriptional regulation of Death Receptor five in pancreatic cancer cells. Cancer Biol. Ther. 2012, 13, 94655. 133. Giles, K.M.; Daly, J.M.; Beveridge, D.J.; Thomson, A.M.; Voon, D.C.; Furneaux, H.M.; Jazayeri, J.
